+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Rx/Reimbursement Adult Incontinence in Kazakhstan

  • ID: 4517566
  • Report
  • March 2021
  • Region: Kazakhstan
  • 18 pages
  • Euromonitor International
Rx/reimbursement adult incontinence sales slowed down a bit in light of the pandemic in both retail volume and current value terms in 2020. Majority of the attention was focused on the away-from home channel which slightly affected sales. Furthermore, consumers also revealed tendencies to save, restricting the performance of Rx/reimbursement adult incontinence as well. Nevertheless, the ageing of the population in Kazakhstan provided a relatively stable consumer group.

The Rx/Reimbursement Adult Incontinence in Kazakhstan report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2016-2020, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2025 illustrate how the market is set to change.

Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

  • Get a detailed picture of the Rx/Reimbursement Adult Incontinence market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Note: Product cover images may vary from those shown
KEY DATA FINDINGS

2020 IMPACT
  • Minimal impact seen from COVID-19 in 2020
  • Consumers remained wary of light options
RECOVERY AND OPPORTUNITIES
  • No long-term impact expected from COVID-19 in the forecast period
  • Ageing population will support future growth
CATEGORY DATA
  • Table 1 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2015-2020
  • Table 2 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2015-2020
  • Table 3 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2020-2025
  • Table 4 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2020-2025
EXECUTIVE SUMMARY
  • COVID-19 impact on tissue and hygiene
  • COVID-19 country impact
  • Company response
  • Retailing shift
  • What next for tissue and hygiene?
MARKET INDICATORS
  • Table 5 Birth Rates 2015-2020
  • Table 6 Infant Population 2015-2020
  • Table 7 Female Population by Age 2015-2020
  • Table 8 Total Population by Age 2015-2020
  • Table 9 Households 2015-2020
  • Table 10 Forecast Infant Population 2020-2025
  • Table 11 Forecast Female Population by Age 2020-2025
  • Table 12 Forecast Total Population by Age 2020-2025
  • Table 13 Forecast Households 2020-2025
MARKET DATA
  • Table 14 Retail Sales of Tissue and Hygiene by Category: Value 2015-2020
  • Table 15 Retail Sales of Tissue and Hygiene by Category: % Value Growth 2015-2020
  • Table 16 NBO Company Shares of Retail Tissue and Hygiene: % Value 2016-2020
  • Table 17 LBN Brand Shares of Retail Tissue and Hygiene: % Value 2017-2020
  • Table 18 Distribution of Retail Tissue and Hygiene by Format: % Value 2015-2020
  • Table 19 Distribution of Retail Tissue and Hygiene by Format and Category: % Value 2020
  • Table 20 Forecast Retail Sales of Tissue and Hygiene by Category: Value 2020-2025
  • Table 21 Forecast Retail Sales of Tissue and Hygiene by Category: % Value Growth 2020-2025
GLOBAL MACROECONOMIC ENVIRONMENT

GLOBAL INDUSTRY ENVIRONMENT

DISCLAIMER

SOURCES
  • Summary 1 Research Sources
Note: Product cover images may vary from those shown
Adroll
adroll